Citius Oncology, Inc. CTOR Effective Income Tax Rate Reconciliation, Percent
Effective Income Tax Rate Reconciliation, Percent at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.
The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s effective income tax rate reconciliation, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s effective income tax rate reconciliation, percent?
- Citius Oncology, Inc. (CTOR) reported effective income tax rate reconciliation, percent of $0.04 in Q3 2025.
- How has Citius Oncology, Inc.'s effective income tax rate reconciliation, percent changed year-over-year?
- Citius Oncology, Inc.'s effective income tax rate reconciliation, percent increased by 59.3% year-over-year, from $0.03 to $0.04.
- What is the long-term trend for Citius Oncology, Inc.'s effective income tax rate reconciliation, percent?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s effective income tax rate reconciliation, percent has grown at a -3.6% compound annual growth rate (CAGR), from $0.08 to $0.08.
- What does effective income tax rate reconciliation, percent mean?
- The ratio of income tax expense to pre-tax income from continuing operations, adjusted for non-recurring items. It provides a standardized view of the company's tax burden on core business activities.